Status:
UNKNOWN
Role of Triptorelin 0.1 mg as a Luteal Phase Support in Assisted Reproductive Technique After Embryo Transfer : a Randomized Controlled Trial
Lead Sponsor:
Moustafa Mohammed Abouelea
Conditions:
Effect of Adding GnRHa as Luteal Phase Support in Antagonist ART Cycles
Eligibility:
FEMALE
20-40 years
Phase:
PHASE3
Brief Summary
There is still controversy over the best LPS agent and protocol and its dose and duration as well as the time of initiation and cessation. There are many protocols of luteal support in assisted repro...
Detailed Description
Type of the study: Open labelled randomized controlled trial Study Setting: ART Unit, Women's Health Hospital c. Sample Size Calculation: Sample size calculation was calculated using Epi Info softwa...
Eligibility Criteria
Inclusion
- Age between 20 to 40 years.
- Baseline FSH \> 10 IU/L.
- Fresh stimulated cycles
- Antagonist cycles
Exclusion
- Uterine fibroid if encroaching uterine cavity.
- Mullerian anomalies.
- Ovarian endometrioma.
- Adnexal hydrosalpinx "except after disconnection".
- Ovarian hyper stimulation syndrome (OHSS) an exaggerated systemic response to ovarian stimulation characterized by a wide spectrum of clinical and laboratory manifestations. It is classified as mild, moderate, or severe according to the degree of abdominal distention, ovarian enlargement, and respiratory, hemodynamic and metabolic complications.
- Poor responders according to bologna criteria.
- Women refused to participate in an RCT.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04087408
Start Date
April 1 2020
End Date
December 31 2022
Last Update
May 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medicine
Asyut, Egypt